Found: 41
Select item for more details and to access through your institution.
De novo methylation of tumor suppressor gene p16/INK4a is a frequent finding in multiple myeloma patients at diagnosis.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Quantitative PCR: an alternative approach to detect common copy number alterations in multiple myeloma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A strategic reflection for the management and implementation of CAR-T therapy in Spain: an expert consensus paper.
- Published in:
- Clinical & Translational Oncology, 2022, v. 24, n. 6, p. 968, doi. 10.1007/s12094-021-02757-9
- By:
- Publication type:
- Article
Current functioning of cardio-oncology units in Spain.
- Published in:
- Clinical & Translational Oncology, 2020, v. 22, n. 8, p. 1418, doi. 10.1007/s12094-019-02250-4
- By:
- Publication type:
- Article
Molecular biology of myeloma.
- Published in:
- Clinical & Translational Oncology, 2007, v. 9, n. 10, p. 618, doi. 10.1007/s12094-007-0114-4
- By:
- Publication type:
- Article
Gene scanning of VDJH-amplified segments is a clinically relevant technique to detect contaminating tumor cells in the apheresis products of multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation.
- Published in:
- Bone Marrow Transplantation, 2001, v. 28, n. 7, p. 665
- By:
- Publication type:
- Article
BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factors.
- Published in:
- Bone Marrow Transplantation, 1997, v. 20, n. 6, p. 451, doi. 10.1038/sj.bmt.1700913
- By:
- Publication type:
- Article
Debate round-table: comments concerning chimerism studies.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Adult precursor B-ALL with BCR/ABL gene rearrangements displays a unique immunophenotype based on the pattern of CD10, CD34, CD13 and CD38 expresssion.
- Published in:
- 2001
- By:
- Publication type:
- journal article
The detection of contaminating clonal cells in apheresis products is related to response and outcome in multiple myeloma undergoing autologous peripheral blood stem cell transplantation.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Deletions and rearrangements of cyclin-dependent kinase 4 inhibitor gene p16 are associated with poor prognosis in B cell non-Hodgkin's lymphomas.
- Published in:
- 1997
- By:
- Publication type:
- journal article
Comorbidities, not age, are predictive of survival after autologous hematopoietic cell transplantation for relapsed/refractory Hodgkin's lymphoma in patients older than 50 years.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Post-Treatment Bone Marrow Residual Disease > 5% by Flow Cytometry Is Highly Predictive of Short Progression-Free and Overall Survival in Patients With Waldenström’s Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 1, p. 168, doi. 10.3816/CLML.2011.n.040
- By:
- Publication type:
- Article
Monoclonal free light chains can be found in heavy chain diseases.
- Published in:
- Annals of Clinical Biochemistry, 2010, v. 47, n. 6, p. 570, doi. 10.1258/acb.2010.010146
- By:
- Publication type:
- Article
The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkin’s lymphoma.
- Published in:
- European Journal of Haematology, 2010, v. 84, n. 3, p. 266, doi. 10.1111/j.1600-0609.2009.01375.x
- By:
- Publication type:
- Article
Effect of cumulative etoposide doses on the outcome of autologous peripheral-blood progenitor-cell transplantation for lymphoma.
- Published in:
- Bone Marrow Transplantation, 2004, v. 33, n. 6, p. 579, doi. 10.1038/sj.bmt.1704401
- By:
- Publication type:
- Article
Proliferative activity of plasma cells is the most relevant prognostic factor in elderly multiple myeloma patients.
- Published in:
- International Journal of Cancer, 2004, v. 112, n. 5, p. 884, doi. 10.1002/ijc.20491
- By:
- Publication type:
- Article
The predominant myeloma clone at diagnosis, CDR3 defined, is constantly detectable across all stages of disease evolution.
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 6, p. 1435, doi. 10.1038/leu.2015.7
- By:
- Publication type:
- Article
Phenotypic identification of subclones in multiple myeloma with different chemoresistant, cytogenetic and clonogenic potential.
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 5, p. 1186, doi. 10.1038/leu.2014.321
- By:
- Publication type:
- Article
Multiparameter flow cytometry for the identification of the Waldenström's clone in IgM-MGUS and Waldenström's Macroglobulinemia: new criteria for differential diagnosis and risk stratification.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 1, p. 166, doi. 10.1038/leu.2013.124
- By:
- Publication type:
- Article
Multiparameter flow cytometry for the identification of the Waldenström's clone in IgM-MGUS and Waldenström's Macroglobulinemia: new criteria for differential diagnosis and risk stratification.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: a case-control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortium.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 7, p. 1615, doi. 10.1038/leu.2013.146
- By:
- Publication type:
- Article
SNP-based mapping arrays reveal high genomic complexity in monoclonal gammopathies, from MGUS to myeloma status.
- Published in:
- Leukemia (08876924), 2012, v. 26, n. 12, p. 2521, doi. 10.1038/leu.2012.128
- By:
- Publication type:
- Article
Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: a case-control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortium.
- Published in:
- Leukemia (08876924), 2012, v. 26, n. 6, p. 1419, doi. 10.1038/leu.2011.352
- By:
- Publication type:
- Article
Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling.
- Published in:
- Leukemia (08876924), 2010, v. 24, n. 3, p. 629, doi. 10.1038/leu.2009.274
- By:
- Publication type:
- Article
Genetic heterogeneity of BCR/ABL<sup>+</sup> adult B-cell precursor acute lymphoblastic leukemia: impact on the clinical, biological and immunophenotypical disease characteristics.
- Published in:
- Leukemia (08876924), 2005, v. 19, n. 5, p. 713, doi. 10.1038/sj.leu.2403714
- By:
- Publication type:
- Article
The oral combination of thalidomide, cyclophosphamide and dexamethasone (ThaCyDex) is effective in relapsed/refractory multiple myeloma.
- Published in:
- Leukemia (08876924), 2004, v. 18, n. 4, p. 856, doi. 10.1038/sj.leu.2403322
- By:
- Publication type:
- Article
Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936.
- Published in:
- Leukemia (08876924), 2003, v. 17, n. 12, p. 2257, doi. 10.1038/sj.leu.2403202
- By:
- Publication type:
- Article
EFFICACY AND SAFETY OF IBRUTINIB IN COMBINATION WITH RITUXIMAB AS FRONTLINE TREATMENT FOR INDOLENT CLINICAL FORMS OF MANTLE CELL LYMPHOMA. RESULTS OF THE GELTAMO IMCL‐2015 STUDY.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.60_2879
- By:
- Publication type:
- Article
PATIENT‐REPORTED OUTCOMES (PROs) IN WALDENSTRÖM MACROGLOBULINEMIA (WM) PATIENTS TREATED WITH IBRUTINIB‐RITUXIMAB IN THE INNOVATE STUDY.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 235, doi. 10.1002/hon.47_2630
- By:
- Publication type:
- Article
PATIENT‐REPORTED OUTCOMES (PROs) IN WALDENSTRÖM MACROGLOBULINEMIA (WM) PATIENTS TREATED WITH IBRUTINIB‐RITUXIMAB IN THE INNOVATE STUDY.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 235, doi. 10.1002/hon.47_2630
- By:
- Publication type:
- Article
Whole-exome analysis of abnormalities leading to Waldenström's macroglobulinemia transformation into aggressive lymphoma.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 283, doi. 10.1002/hon.2439_10
- By:
- Publication type:
- Article
Pegylated liposomal doxorubicin, melphalan and prednisone therapy for elderly patients with multiple myeloma.
- Published in:
- Hematological Oncology, 2006, v. 24, n. 4, p. 205, doi. 10.1002/hon.790
- By:
- Publication type:
- Article
Killer‐cell immunoglobulin‐like receptor polymorphism is associated with COVID‐19 outcome: Results of a pilot observational study.
- Published in:
- HLA: Immune Response Genetics, 2024, v. 104, n. 2, p. 1, doi. 10.1111/tan.15640
- By:
- Publication type:
- Article
Low expression of ZHX2, but not RCBTB2 or RAN, is associated with poor outcome in multiple myeloma.
- Published in:
- British Journal of Haematology, 2008, v. 141, n. 2, p. 212, doi. 10.1111/j.1365-2141.2007.06956.x
- By:
- Publication type:
- Article
Randomized comparison of dexamethasone combined with melphalanversusmelphalan with prednisone in the treatment of elderly patients with multiple myeloma.
- Published in:
- British Journal of Haematology, 2004, v. 127, n. 2, p. 159, doi. 10.1111/j.1365-2141.2004.05186.x
- By:
- Publication type:
- Article
Thalidomide in combination with cyclophosphamide and dexamethasone (thacydex) is effective in soft-tissue plasmacytomas.
- Published in:
- British Journal of Haematology, 2002, v. 119, n. 3, p. 883, doi. 10.1046/j.1365-2141.2002.03870_8.x
- By:
- Publication type:
- Article
Bisphosphonate-related osteonecrosis: genetic and acquired risk factors.
- Published in:
- Oral Diseases, 2009, v. 15, n. 6, p. 382, doi. 10.1111/j.1601-0825.2009.01568.x
- By:
- Publication type:
- Article
Management of mixed acute rejection driven by a de novo donor-specific complement-binding anti-DQB1*03:01 antibody and intraepithelial CD8 T-cells in a kidney recipient: a case report.
- Published in:
- British Journal of Biomedical Science, 2021, v. 78, n. 4, p. 244, doi. 10.1080/09674845.2021.1927308
- By:
- Publication type:
- Article
Expression of the CD117 antigen (C-Kit) on normal and myelomatous plasma cells.
- Published in:
- British Journal of Haematology, 1996, v. 95, n. 3, p. 489, doi. 10.1111/j.1365-2141.1996.tb08993.x
- By:
- Publication type:
- Article
Analysis of natural killer-associated antigens in peripheral blood and bone marrow of multiple myeloma patients and prognostic implications.
- Published in:
- British Journal of Haematology, 1996, v. 93, n. 1, p. 81, doi. 10.1046/j.1365-2141.1996.4651006.x
- By:
- Publication type:
- Article